Viability and apoptosis measured by imaging in BRAF(V600E/D) melanoma cell lines following treatment with combinations of three compounds (viability/apoptosis dataset 2 of 2) - Dataset (ID:20273)

Filter results: >>>>
Cell Small Molecule 1 Small Molecule 2 Small Molecule 3 Small Mol 1 Concentration Small Mol 2 Concentration Small Mol 3 Concentration Small Mol Conc Unit Time Point Time Point Unit Replicate Total Number of Cells (Nuclei) Number of Apoptotic Cells Relative Viability Mean Relative Viability Apoptosis Fraction Mean Apoptosis Fraction
WM-115 Vemurafenib Trametinib I-BET151 1.0000 0.1000 0.0000
uM
72
hr
3 1639 471 0.3389 0.3359 0.2874 0.2966
WM-115 Vemurafenib Trametinib I-BET151 1.0000 0.1000 1.0000
uM
72
hr
1 934 658 0.0801 0.0721 0.7045 0.7260
WM-115 Vemurafenib Trametinib I-BET151 1.0000 0.1000 1.0000
uM
72
hr
2 910 675 0.0682 0.0721 0.7418 0.7260
WM-115 Vemurafenib Trametinib I-BET151 1.0000 0.1000 1.0000
uM
72
hr
3 872 638 0.0679 0.0721 0.7317 0.7260
WM-115 Vemurafenib Trametinib I-BET151 3.1600 0.3160 0.0000
uM
72
hr
1 1261 597 0.1927 0.2080 0.4734 0.4511
WM-115 Vemurafenib Trametinib I-BET151 3.1600 0.3160 0.0000
uM
72
hr
2 1353 550 0.2330 0.2080 0.4065 0.4511
WM-115 Vemurafenib Trametinib I-BET151 3.1600 0.3160 0.0000
uM
72
hr
3 1297 614 0.1982 0.2080 0.4734 0.4511
WM-115 Vemurafenib Trametinib I-BET151 3.1600 0.3160 1.0000
uM
72
hr
1 775 600 0.0508 0.0514 0.7742 0.7604
WM-115 Vemurafenib Trametinib I-BET151 3.1600 0.3160 1.0000
uM
72
hr
2 737 556 0.0525 0.0514 0.7544 0.7604
WM-115 Vemurafenib Trametinib I-BET151 3.1600 0.3160 1.0000
uM
72
hr
3 707 532 0.0508 0.0514 0.7525 0.7604